An analysis by Pharmarack, a market research firm, showed that 226 vildagliptin (anti-diabetic) brands are now available in ...
The 15 medicines included in the initiative include three branded medicines: valsartan for hypertension; vildagliptin for diabetes and breast cancer therapy letrozole (breast cancer). It also ...
Am J Health Syst Pharm. 2007;64(12):1265-1273.
The firm already markets recently-approved Entresto (sacubitril+valsartan) to treat heart failure, and diabetes drug Galvus (vildagliptin) through its cardio-metabolic division, and is looking to ...
It launched a combination drug Vildanat M (Vildagliptin and Metformin) for diabetes, to achieve better blood glucose control and improve therapy compliance.During the period 2019-20, NATCO Life ...
Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, following the expiry of its patent. Estimated to significantly cut costs and ...
Sitagliptin (Januvia™) is a new oral agent approved by the US FDA to treat Type 2 diabetes. This is the first approved agent in a new class of antihyperglycemics, dipeptidyl peptidase (DPP)-4 ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback